Liberia declared free of Ebola transmission
11 May 2015 | By Victoria White
WHO has declared Liberia free of Ebola transmission - forty-two days have passed since the last laboratory-confirmed case was buried...
List view / Grid view
News
Pivotal data for Roche medicines in lung and blood cancers to be presented at ASCO 2015
11 May 2015 | By Victoria White
Roche has announced that data from 10 of its approved cancer medicines and 10 of its investigational medicines will be presented at this year’s American Society of Clinical Oncology Annual Meeting (ASCO 2015).
WHO issues best practice advice for disease names
8 May 2015 | By Victoria White
WHO has called on scientists, national authorities and the media to follow best practices for disease names to minimise unnecessary negative effects...
FDA lifts clinical hold on ND0612H and ND0612L for the treatment of Parkinson’s disease
8 May 2015 | By
The FDA has lifted the clinical hold on clinical studies of ND0612H and ND0612L, NeuroDerm's product candidates for the treatment of Parkinson’s disease...
FDA grants fast track designation to Sucampo’s cobiprostone for oral mucositis
8 May 2015 | By Victoria White
The FDA has granted Fast Track Designation for cobiprostone, a locally acting chloride channel activator, for the prevention of oral mucositis.
Clinical data on EBI-005 for the treatment of dry eye disease and allergic conjunctivitis presented at ARVO 2015
8 May 2015 | By Victoria White
Eleven Biotherapeutics presented clinical data for EBI-005 for dry eye disease and allergic conjunctivitis at the ARVO 2015 Annual Meeting...
EC approves Zykadia for treatment of patients with ALK+ NSCLC
8 May 2015 | By Victoria White
The European Commission has approved Novartis’ Zykadia to treat adult patients with ALK+ NSCLC previously treated with crizotinib...
Asia-Pacific market for psoriasis treatment to almost double to $1.2 billion by 2021, says GBI Research
8 May 2015 | By Victoria White
The Asia-Pacific treatment market for psoriasis will almost double in value, from $690 million in 2014 to $1.2 billion by 2021, representing a CAGR of 8.4%...
Ohr Pharmaceutical presents data from OHR-102 Phase II study in wet-AMD
7 May 2015 | By Victoria White
Ohr Pharmaceutical presented the results from the Phase II IMPACT study evaluating OHR-102 combination therapy for the treatment of the wet-AMD at ARVO...
Quotient Clinical reports another successful year of record growth
7 May 2015 | By kdm communications
Operating capacity set to more than double in response to rising demand...
Bill & Melinda Gates Foundation to fund CHAMPS – a network of disease surveillance sites
7 May 2015 | By Victoria White
The Bill & Melinda Gates Foundation are set to announce CHAMPS - a network of disease surveillance sites in developing countries...
Johnson & Johnson announces groundbreaking partnership to evaluate compassionate use requests of investigational medicines
7 May 2015 | By Victoria White
J&J has announced a first-of-its-kind partnership that enlists a third party to review compassionate use requests made for investigational medicines...
Alexion to acquire Synageva in $8.4 billion deal
7 May 2015 | By Victoria White
Alexion Pharmaceuticals has announced that it is set to acquire Synageva BioPharma in a transaction valued at approximately $8.4 billion...
FDA grants Breakthrough Therapy Designation for venetoclax in 17p deletion relapsed-refractory chronic lymphocytic leukaemia
7 May 2015 | By Victoria White
The FDA has granted Breakthrough Therapy Designation for venetoclax for the treatment of people who have relapsed or refractory CLL with 17p deletion...
Nulojix regimen beats cyclosporine in 7-year trial in kidney transplant patients
7 May 2015 | By
A 7-year study of a Nulojix regimen has demonstrated a significant relative risk reduction of death or transplant failure over a cyclosporine regimen...
